Celgene (CELG) options active as shares sell off 8% on revlimid data
Tweet Send to a Friend
Celgene (Nasdaq: CELG) December 55 calls and January 55 puts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
